GLP1R and Wolfram syndrome: Exenatide and forskolin further improve mitochondrial function, reduce oxidative stress and prevent apoptosis in Wolfram iPSC-derived NPCs and cerebellar neurons, indicating that GLP-1R agonists have indeed therapeutic potential to prevent or delay neurodegeneration in Wolfram syndrome.